<p>Analysis of Differential Expression Proteins of Paclitaxel-Treated Lung Adenocarcinoma Cell A549 Using Tandem Mass Tag-Based Quantitative Proteomics</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Analysis of Differential Expression Proteins of Paclitaxel-Treated Lung Adenocarcinoma Cell A549 Using Tandem Mass Tag-Based Quantitative Proteomics

Published:2020-10 Issue: Volume:Volume 13 Page:10297-10313
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Zheng Wanchun,Xu Shouming

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Reference58 articles.

1. Cancer statistics, 2015

2. Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

3. Cancer statistics, 2018

4. Inhibition of Phosphatidylinositol 3-kinase (PI3K) Signaling Synergistically Potentiates Antitumor Efficacy of Paclitaxel and Overcomes Paclitaxel-Mediated Resistance in Cervical Cancer

5. Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abnormalities of the Serum Proteomic in Thrombosis After Central Venous Catheter (CVC) Insertion in Patients with End-stage Kidney Disease;TRANSPLANTATION;2023

2. Proteomics identifies differentially expressed proteins in glioblastoma U87 cells treated with hederagenin;Proteome Science;2023-04-29

3. Paclitaxel sensitizes homologous recombination-proficient ovarian cancer cells to PARP inhibitor via the CDK1/BRCA1 pathway;Gynecologic Oncology;2023-01

4. An in-vivo-mimicking 3D lung cancer-on-a-chip model to study the effect of external stimulus on the progress and inhibition of cancer metastasis;Bioprinting;2022-12

5. NUF2 Expression Promotes Lung Adenocarcinoma Progression and Is Associated With Poor Prognosis;Frontiers in Oncology;2022-06-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3